Scott Ryan (Victoria, Liberal Party, Assistant Cabinet Secretary) Share this | Hansard source

The Australian government is committed to the prevention, testing and treatment of HIV in Australia and delivering on the actions and objections of the Seventh National HIV Strategy 2014-2017. To extend the use of a medicine already registered on the Australian register of therapeutic goods to include additional clinical indications such as for pre-exposure prophylactic use, it is necessary for the sponsor of that product to submit an application to the Therapeutic Goods Administration. Neither the TGA nor the Australian government is able to compel a sponsor to submit such an application. There are demonstration and trial projects underway in several states that will provide an important evidence base with which to discuss and draft a national policy regarding pre-exposure prophylactic use.

Question agreed to.